Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?

Laura Evangelista,Anna Rita Cervino,Cristina Ghiotto,Tania Saibene,Silvia Michieletto,Bozza Fernando,Enrico Orvieto,Valentina Guarneri,Pierfranco Conte

Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?

2015

Laura Evangelista
Anna Rita Cervino
Cristina Ghiotto
Tania Saibene
Silvia Michieletto
Bozza Fernando
Enrico Orvieto
Valentina Guarneri
Pierfranco Conte

Purpose We investigated whether maximum standardized uptake value (SUVmax), metabolic tumour volume (MTV), total lesion glycolysis (TLG) and whole-body (WB) SUVmax, WB MTV and WB TLG measured by 18F-FDG PET/CT could improve prognostic stratification in patients with stage II/III breast cancer (BC).

Keywords:

Breast cancer
Radiology
Medicine
Lesion
Tumour volume
Positron emission tomography
Neoadjuvant therapy
Standardized uptake value
Retrospective cohort study
in patient
neoadjuvant treatment
stage ii

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations